发明名称 |
SUBSTITUTED AMIDE COMPOUNDS |
摘要 |
The present invention is directed at substituted amide compounds, pharmaceutical compositions containing such compounds and the use of such compounds to reduce plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans. |
申请公布号 |
US2014315928(A1) |
申请公布日期 |
2014.10.23 |
申请号 |
US201414253084 |
申请日期 |
2014.04.15 |
申请人 |
Pfizer Inc. |
发明人 |
Darout Etzer;Dullea Robert;Hawkins Julie Jia Li;Londregan Allyn T.;Loria Paula M.;Maguire Bruce;McClure Kim F.;Petersen Donna N.;Piotrowski David W. |
分类号 |
C07D401/14;A61K31/519;A61K45/06;C07D413/14;A61K31/437;A61K31/4709;A61K31/4545;C07D487/04;C07D471/04 |
主分类号 |
C07D401/14 |
代理机构 |
|
代理人 |
|
主权项 |
1. A compound having Formula I or a pharmaceutically acceptable salt thereof wherein R1 is pyrid-2-yl, isoquinolin-1-yl or 1H-pyrrolo[2,3-c]pyridin-7-yl; R1 is optionally mono- or di-substituted with chloro or (C1-C4)alkyl; X and Y are independently either N or C(H), provided that at least one of X or Y is C(H); R2 is H, fluoro, hydroxyl or methyl; R3 is wherein R6 and R8 are each independently H, methyl, halo or (C1-C4)alkyloxy, provided that only one of R6 and R8 is halo; wherein R10 and R11 are each independently H, (C1-C4)alkyl or (C3-C5)cycloalkyl; and wherein R7 is hydroxyl, (C1-C4)alkyloxy, (C1-C4)alkoxycarbonyloxy(C1-C4)alkyloxy, or (C1-C4)alkylcarbonyloxy(C1-C4)alkoxy. |
地址 |
New York NY US |